Idelalisib
Dec. 24, 2024
Idelalisib - Wikipedia Zydelig (idelalisib) for the Treatment of Three B-cell Blood Cancers - Clinical Trials Arena Idelalisib (CAL-101) | PI3Kδ Inhibitor | MedChemExpress Idelalisib | C22H18FN7O - PubChem Idelalisib: a Selective Inhibitor of the Delta Isoform of Phosphatidylinositol 3-Kinase | Personalized Medicine in Oncology Idelalisib | ≥99%(HPLC) | Selleck | PI3K inhibitor | Idelalisib